A Nature Communications study ties declining liver integrity to adaptive β-catenin-driven tumorigenesis, spotlighting how tissue structure may actively enable cancer progression. The work, led by Illendula, Hewett, Hayata, and colleagues, examines the mechanism by which β-catenin—normally involved in maintaining tissue homeostasis—shifts toward promoting cancer when the liver becomes increasingly vulnerable. The report centers on the concept that tumor risk may rise not only from genetic alterations in cells but also from changes in the organ’s structural context that reprogram signaling pathways. β-catenin is positioned as the central switch, potentially linking microenvironmental deterioration to oncogenic behavior. For drug development, the finding adds mechanistic support for strategies that modulate β-catenin signaling in liver disease contexts where tissue integrity is compromised.